Monday, June 25, 2018

No Greater Amputation Risk with Canagliflozin in T2D Patients

  1. No Greater Amputation Risk with Canagliflozin in T2D Patients  MedPage Today
  2. OBSERVE-4D: No amputation risk with canagliflozin in type 2 diabetes  Healio
  3. Real World Study Suggests Canagliflozin Does Not Increase Risk of Below-Knee Amputation in People with Type 2 ...  Idaho State JournalFull coverage
(CLICK HERE TO READ AND SEE MORE

0 comments:

Post a Comment